Summit Financial Wealth Advisors’s Altimmune ALT Stock Holding History

Summit Financial Wealth Advisors’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$314K	Hold	103,288	–	–	0.04%	173
2026 Q1	$318K	Hold	103,288	–	–	0.05%	148
2025 Q4	$373K	Buy	103,288 +7,000	+7%	+$30.5K	0.05%	132
2025 Q3	$373K	Sell	96,288 -26,700	-22%	-$103K	0.06%	121
2025 Q2	$476K	Buy	122,988 +5,000	+4%	+$27.1K	0.09%	97
2025 Q1	$590K	Buy	117,988 +18,500	+19%	+$117K	0.12%	84
2024 Q4	$641K	Buy	99,488 +53,570	+117%	+$409K	0.13%	82
2024 Q3	$282K	Buy	45,918 +18,113	+65%	+$123K	0.05%	124
2024 Q2	$185K	Buy	+27,805	New	+$205K	0.04%	140

Other funds holding ALT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Summit Financial Wealth Advisors's ALT Position: Q2 2026 in Review

Summit Financial Wealth Advisors held its Altimmune (ALT) position steady in Q2 2026 at 103,288 shares worth $314K. The position accounts for 0.04% of the portfolio, ranked #173.

Summit Financial Wealth Advisors first reported a position in ALT in Q2 2024 and has held it in 9 quarters since. The position peaked at $641K in Q4 2024. 211 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

Summit Financial Wealth Advisors held 103,288 shares of Altimmune worth $314K as of Q2 2026.
Summit Financial Wealth Advisors left its Altimmune share count unchanged in Q2 2026.
Altimmune made up 0.04% of Summit Financial Wealth Advisors's portfolio in Q2 2026, its #173 holding.
Summit Financial Wealth Advisors first reported a position in Altimmune in Q2 2024 and has held it in 9 quarters since.
Summit Financial Wealth Advisors's Altimmune position peaked at $641K in Q4 2024.
211 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Summit Financial Wealth Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.